Translated automatically – community improvements welcome.
N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-hep…
Cyclobenzaprine is a centrally acting muscle relaxant that is structurally related to tricyclic antidepressants. It primarily acts by inhibiting alpha2-adrenergic receptors and possesses anticholinergic properties. The substance is used to treat muscle spasms and can induce sedative effects. Side effects may include dry mouth, drowsiness, and cardiovascular effects.
Mechanism of Action
- alpha2-adrenergic inhibition
- anticholinergic activity
Names / Identifiers
IUPAC: Cyclobenzaprine
Mechanism of Action
Cyclobenzaprin wirkt als Muskelrelaxans, indem es die zentrale Hemmung von spinalen Reflexen fördert und die serotonergen und noradrenergen Systeme beeinflusst.
Effects
Effects described from scientific sources. Individual experiences vary.
Dosage
Individual sensitivity varies. Not a dosage recommendation.
Duration
Risks & Warnings
Warnings
- Acute myocardial infarction
- Hyperthyroidism
- Glaucoma
Known Risks
- medium
- Kann Schläfrigkeit, Schwindel und anticholinerge Effekte verursachen.
Safer Use
- Avoid alcohol and other sedating substances.
- Do not drive if you feel drowsy.
Harm reduction tips do not replace medical advice.
Known Interactions
- MAO inhibitors
- other CNS depressants
This list is not exhaustive. Interactions can have unpredictable effects.
Legal Status
Not legal advice. Status may change.
Entdecken
Ähnliche Substanzen
Basierend auf Substanzklasse, Rezeptoren, Wirkmechanismen und Wirkprofil.